Campus News Banner


Developing Health Care Businesses

Contact: Chuck Ham

 

""

Baxter is director of Metabolic Research Unit, University of California School of Medicine, San Francisco, and is chief of the Division of Endocrinology at Moffitt Hospital. He holds the rank of professor in the Department of Medicine and Department of Biochemistry and Biophysics at UCSF. Using genetic engineering techniques, Baxter and his colleagues were the first to produce animal and human growth hormone by recombinant and DNA techniques.

""

LEXINGTON, Ky. (Dec. 1, 2003) -- Lexington native John D. Baxter, M.D. will give a free lecture on “Developing Health Care Related Business Activity in Lexington” at 2 p.m. Thursday, Dec. 4, in MN-363 of the William R. Willard Medical Sciences Building at the University of Kentucky as a part of the UK College of Medicine Dean’s Lecture Series.

Baxter developed and served on the boards of several start-up companies, including SciClone, California Biotechnology (recently sold to Johnson & Johnson), Karo Bio, and Calhoun Vision.

Baxter is director of Metabolic Research Unit, University of California School of Medicine, San Francisco, and is chief of the Division of Endocrinology at Moffitt Hospital. He holds the rank of professor in the Department of Medicine and Department of Biochemistry and Biophysics at UCSF. Using genetic engineering techniques, Baxter and his colleagues were the first to produce animal and human growth hormone by recombinant and DNA techniques.

A graduate of Lafayette High School, Baxter received a cum laude bachelor’s degree in chemistry in 1962 from UK, where he was a member of Phi Beta Kappa and the UK track and field team. He is a cum laude graduate of Yale University School of Medicine. In 1980, he was inducted into the UK Alumni Association Hall of Distinguished Alumni.


Back to Campus News Homepage